Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool

Autor: Sean J. Barbour, Mark Canney, Rosanna Coppo, Hong Zhang, Zhi-Hong Liu, Yusuke Suzuki, Keiichi Matsuzaki, Ritsuko Katafuchi, Dilshani Induruwage, Lee Er, Heather N. Reich, John Feehally, Jonathan Barratt, Daniel C. Cattran, M.L. Russo, S. Troyanov, H.T. Cook, I. Roberts, V. Tesar, D. Maixnerova, S. Lundberg, L. Gesualdo, F. Emma, L. Fuiano, G. Beltrame, C. Rollino, A. Amore, R. Camilla, L. Peruzzi, M. Praga, S. Feriozzi, R. Polci, G. Segoloni, L. Colla, A. Pani, D. Piras, A. Angioi, G. Cancarini, S. Ravera, M. Durlik, E. Moggia, J. Ballarin, S. Di Giulio, F. Pugliese, I. Serriello, Y. Caliskan, M. Sever, I. Kilicaslan, F. Locatelli, L. Del Vecchio, J.F.M. Wetzels, H. Peters, U. Berg, F. Carvalho, A.C. da Costa Ferreira, M. Maggio, A. Wiecek, M. Ots-Rosenberg, R. Magistroni, R. Topaloglu, Y. Bilginer, M. D’Amico, M. Stangou, F. Giacchino, D. Goumenos, P. Kalliakmani, M. Gerolymos, K. Galesic, C. Geddes, K. Siamopoulos, O. Balafa, M. Galliani, P. Stratta, M. Quaglia, R. Bergia, R. Cravero, M. Salvadori, L. Cirami, B. Fellstrom, H. Kloster Smerud, F. Ferrario, T. Stellato, J. Egido, C. Martin, J. Floege, F. Eitner, A. Lupo, P. Bernich, P. Menè, M. Morosetti, C. van Kooten, T. Rabelink, M.E.J. Reinders, J.M. Boria Grinyo, S. Cusinato, L. Benozzi, S. Savoldi, C. Licata, M. Mizerska-Wasiak, G. Martina, A. Messuerotti, A. Dal Canton, C. Esposito, C. Migotto, G. Triolo, F. Mariano, C. Pozzi, R. Boero, S. Bellur, G. Mazzucco, C. Giannakakis, E. Honsova, B. Sundelin, A.M. Di Palma, E. Gutiérrez, A.M. Asunis, J. Barratt, R. Tardanico, A. Perkowska-Ptasinska, J. Arce Terroba, M. Fortunato, A. Pantzaki, Y. Ozluk, E. Steenbergen, M. Soderberg, Z. Riispere, L. Furci, D. Orhan, D. Kipgen, D. Casartelli, D. Galesic Ljubanovic, H. Gakiopoulou, E. Bertoni, P. Cannata Ortiz, H. Karkoszka, H.J. Groene, A. Stoppacciaro, I. Bajema, J. Bruijn, X. Fulladosa Oliveras, J. Maldyk, E. Ioachim, N. Bavbek, T. Cook, C. Alpers, F. Berthoux, S. Bonsib, V. D’Agati, G. D’Amico, S. Emancipator, F. Emmal, F. Fervenza, S. Florquin, A. Fogo, H. Groene, M. Haas, P. Hill, R. Hogg, S. Hsu, T. Hunley, M. Hladunewich, C. Jennette, K. Joh, B. Julian, T. Kawamura, F. Lai, C. Leung, L. Li, P. Li, Z. Liu, A. Massat, B. Mackinnon, S. Mezzano, F. Schena, Y. Tomino, P. Walker, H. Wang, J. Weening, N. Yoshikawa N, C.-H. Zeng, S. Shi, C. Nogi, H. Suzuki, K. Koike, K. Hirano, T. Yokoo, M. Hanai, K. Fukami, K. Takahashi, Y. Yuzawa, M. Niwa, Y. Yasuda, S. Maruyama, D. Ichikawa, T. Suzuki, S. Shirai, A. Fukuda, S. Fujimoto, H. Trimarchi

Publikováno v: Kidney international, 98(4), 1009-1019. Nature Publishing Group
Kidney International, 98, 4, pp. 1009-1019
Kidney International, 98, 1009-1019

Contains fulltext : 225968.pdf (Publisher’s version ) (Closed access) Immunosuppression in IgA nephropathy (IgAN) should be reserved for patients at high-risk of disease progression, which KDIGO guidelines determine based solely on proteinuria 1g o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a30eea7fd7489265252419d233f2e8e8
https://pure.amc.nl/en/publications/improving-treatment-decisions-using-personalized-risk-assessment-from-the-international-iga-nephropathy-prediction-tool(d812809c-0a7b-4a59-a449-e693d5ed0f19).html

The MEST score provides earlier risk prediction in lgA nephropathy

Autor: Sean J. Barbour, Gabriela Espino-Hernandez, Heather N. Reich, Rosanna Coppo, Ian S.D. Roberts, John Feehally, Andrew M. Herzenberg, Daniel C. Cattran, N. Bavbek, T. Cook, S. Troyanov, C. Alpers, A. Amore, J. Barratt, F. Berthoux, S. Bonsib, J. Bruijn, V. D’Agati, G. D’Amico, S. Emancipator, F. Emmal, F. Ferrario, F. Fervenza, S. Florquin, A. Fogo, C. Geddes, H. Groene, M. Haas, P. Hill, R. Hogg, S. Hsu, T. Hunley, M. Hladunewich, C. Jennette, K. Joh, B. Julian, T. Kawamura, F. Lai, C. Leung, L. Li, P. Li, Z. Liu, A. Massat, B. Mackinnon, S. Mezzano, F. Schena, Y. Tomino, P. Walker, H. Wang, J. Weening, N. Yoshikawa, H. Zhang, R. Coppo, D.C. Cattran, H.T. Cook, J. Feehally, I. Roberts, V. Tesar, D. Maixnerova, S. Lundberg, L. Gesualdo, F. Emma, L. Fuiano, G. Beltrame, C. Rollino, null RC, R. Camilla, L. Peruzzi, M. Praga, S. Feriozzi, R. Polci, G. Segoloni, L. Colla, A. Pani, A. Angioi, L. Piras, null JF, G. Cancarini, S. Ravera, M. Durlik, E. Moggia, J. Ballarin, S. Di Giulio, F. Pugliese, I. Serriello, Y. Caliskan, M. Sever, I. Kilicaslan, F. Locatelli, L. Del Vecchio, J.F.M. Wetzels, H. Peters, U. Berg, F. Carvalho, A.C. da Costa Ferreira, M. Maggio, A. Wiecek, M. Ots-Rosenberg, R. Magistroni, R. Topaloglu, Y. Bilginer, M. D’Amico, M. Stangou, F. Giacchino, D. Goumenos, P. Kalliakmani, M. Gerolymos, K. Galesic, K. Siamopoulos, O. Balafa, M. Galliani, P. Stratta, M. Quaglia, R. Bergia, R. Cravero, M. Salvadori, L. Cirami, B. Fellstrom, H. Kloster Smerud, T. Stellato, J. Egido, C. Martin, J. Floege, F. Eitner, A. Lupo, P. Bernich, P. Menè, M. Morosetti, C. van Kooten, T. Rabelink, M.E.J. Reinders, J.M. Boria Grinyo, S. Cusinato, L. Benozzi, S. Savoldi, C. Licata, M. Mizerska-Wasiak, G. Martina, A. Messuerotti, A. Dal Canton, C. Esposito, C. Migotto, G. Triolo, F. Mariano, C. Pozzi, R. Boero, S. Bellur, G. Mazzucco, C. Giannakakis, E. Honsova, B. Sundelin, A.M. Di Palma, E. Gutiérrez, A.M. Asunis, R. Tardanico, A. Perkowska-Ptasinska, J. Arce Terroba, M. Fortunato, A. Pantzaki, Y. Ozluk, E. Steenbergen, M. Soderberg, Z. Riispere, L. Furci, D. Orhan, D. Kipgen, D. Casartelli, D. Galesic Ljubanovic, H. Gakiopoulou, E. Bertoni, P. Cannata Ortiz, H. Karkoszka, H.J. Groene, A. Stoppacciaro, I. Bajema, X. Fulladosa Oliveras, J. Maldyk, E. Ioachim

Publikováno v: Kidney International. Supplement, 89, 167-75
Kidney International. Supplement, 89, 1, pp. 167-75
Kidney International, 89(1), 167-175. Elsevier Inc.
Kidney international, 89(1), 167-175. Nature Publishing Group

Item does not contain fulltext The Oxford Classification of IgA nephropathy (IgAN) includes the following four histologic components: mesangial (M) and endocapillary (E) hypercellularity, segmental sclerosis (S) and interstitial fibrosis/tubular atro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac728346b01272b9e10840eac0608698
https://doi.org/10.1038/ki.2015.322

SUN-036 SPLEEN TYROSINE KINASE (SYK) INHIBITION IN IGA NEPHROPATHY: A GLOBAL, PHASE II, RANDOMISED PLACEBO-CONTROLLED TRIAL OF FOSTAMATINIB

Autor: F. Tam WK, J. Tumlin, J. Barratt, B. Rovin H, I. Roberts SD, C. Roufosse, H.T. Cook, S. Tong, D. Magilavy, R. Lafayette

Publikováno v: Kidney International Reports. 4:S168

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::02c989c73443d0b27cbcc58bbe691b58
https://doi.org/10.1016/j.ekir.2019.05.431

Recurrence of Complement Factor H-Related Protein 5 Nephropathy in a Renal Transplant

Autor: Katherine A. Vernon, David Taube, Jack Galliford, H.T. Cook, E. Goicoechea de Jorge, Adam McLean, Patrick H. Maxwell, Matthew C. Pickering, Alkis Pierides, Daniel P. Gale

Publikováno v: American Journal of Transplantation

Complement factor H-related protein 5 (CFHR5) nephropathy is a familial renal disease endemic in Cyprus. It is characterized by persistent microscopic hematuria, synpharyngitic macroscopic hematuria and progressive renal impairment. Isolated glomerul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2c59cc3fd109038dd5f898a49180419
https://doi.org/10.1111/j.1600-6143.2010.03333.x

A lupus-susceptibility C57BL/6 locus on chromosome 3 (Sle18) contributes to autoantibody production in 129 mice

Autor: Marina Botto, Mark Walport, Y Heidari, Francesco Carlucci, H.T. Cook, Liliane Fossati-Jimack

Publikováno v: Genes & Immunity. 10:47-55

Epistatic interactions between the non-autoimmune strains 129 and C57BL/6 (B6), used for generating gene-targeted animals, can induce a lupus-like disease. Genome-wide scan analyses of testcross progeny between these two strains have identified sever

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbdd51579603b5a1b0593fd30b21299e
https://doi.org/10.1038/gene.2008.78